Dr. Cory Henderson
- Co-Founder & CEO
Dr. Cory Henderson is a molecular biologist and the Co-Founder and Chief Executive Officer of Evolv, the biomimetics company behind the first oral GLP-1 supplement designed for everyday metabolic health.
Henderson earned his Ph.D. in Molecular, Cellular, and Integrative Biosciences from Penn State University in 2021, where he was awarded a National Science Foundation Graduate Research Fellowship — one of the most competitive early-career honors in U.S. science. His doctoral research focused on arbovirus transmission and host–pathogen interactions, producing peer-reviewed publications in the Journal of Virology, PLOS Neglected Tropical Diseases, and G3: Genes, Genomes, Genetics.
Following his doctorate, Henderson completed postdoctoral research at Rutgers University–New Brunswick, where he used bioinformatic and molecular approaches to study vector-borne pathogen transmission and mosquito immunity. This work in molecular biology and disease vector research laid the foundation for the biological platform that would become Evolv.
As Co-Inventor of the EV1 Peptide™, Henderson translated his background in molecular biology into the creation of a novel biomimetic molecule — a GLP-1 and GIP receptor agonist produced through a proprietary engineered yeast strain. He directs Evolv’s scientific roadmap, clinical study program, and product development pipeline, applying pharmaceutical-grade rigor to consumer health.
Henderson’s leadership bridges the gap between laboratory science and accessible wellness solutions. Under his direction, Evolv’s third-party clinical testing has demonstrated measurable outcomes in weight management and appetite regulation, with the company pioneering the biomimetics category as a new standard in supplement science.
He is based in San Francisco, California.
Credentials
Education
Ph.D., Molecular, Cellular & Integrative Biosciences — Penn State University
Fellowship
National Science Foundation Graduate Research Fellow
Postdoctoral Research
Rutgers University–New Brunswick
Specialization
Molecular biology, genetic engineering, arbovirus transmission, peptide design
Co-Inventor
EV1 Peptide™
Location
San Francisco, CA
Published research
Selected peer-reviewed publications from Dr. Henderson's doctoral research at Penn State. This work established his foundation in molecular biology, host–pathogen interactions, and the genomic and transcriptomic techniques.
Henderson C, Brustolin M, Hegde S, et al. Transcriptomic and small RNA response to Mayaro virus infection in Anopheles stephensi mosquitoes. PLOS Neglected Tropical Diseases. 2022;16(6):e0010507. (PubMed)
Henderson C, Kemirembe K, McKeand S, Bergey C, Rasgon JL. Novel genome sequences and evolutionary dynamics of the North American anopheline species. G3 (Bethesda). 2023;13(1):jkac284. (PubMed)
Brustolin M, Pujhari S, Terradas G, et al. In Vitro and In Vivo Coinfection and Superinfection Dynamics of Mayaro and Zika Viruses. Journal of Virology. 2023;97(1):e0177822. (PubMed)
Brustolin M, Pujhari S, Henderson CA, Rasgon JL. Anopheles mosquitoes may drive invasion and transmission of Mayaro virus. PLOS Neglected Tropical Diseases. 2018;12(11):e0006895. (PubMed)
